ArticleFrontiers in oncology2021

Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report.

Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.